Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-017717
Filing Date
2022-06-21
Accepted
2022-06-21 18:24:58
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165585028468206.html 4  
1 FORM 4 wf-form4_165585028468206.xml 4 3787
  Complete submission text file 0001628280-22-017717.txt   5296
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O CHROMADEX CORPORATION 10900 WILSHIRE BLVD. STE 600 LOS ANGELES CA 90024
Business Address
Cohen Ann (Reporting) CIK: 0001923843 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37752 | Film No.: 221029390